Impact of COVID-19 on female fertility: a systematic review and meta-analysis protocol

Fangyuan Li, Hua Lu, Qi Zhang, Xinyun Li, Tong Wang, Qianchen Liu, Qian Yang, Lingxia Qiang, Fangyuan Li, Hua Lu, Qi Zhang, Xinyun Li, Tong Wang, Qianchen Liu, Qian Yang, Lingxia Qiang

Abstract

Introduction: The increased social and economic burden caused by the novel COVID-19 outbreak is gradually becoming a worrisome issue for the health sector. The novel coronavirus invades the target cell by binding to ACE2, which is widely expressed in the ovaries, uterus, vagina and placenta. Significantly, the SARS-CoV-2 is said to interrupt female fertility through regulating ACE2. Thus, it is essential to investigate if the novel COVID-19 hampers female fertility, given that there is no systematic and comprehensive evidence on the association of COVID-19 with female fertility.

Methods and analysis: We will systematically search cohort studies, cross-sectional studies, case-control studies and self-controlled case series designs in the following databases: Web of Science, PubMed, EMBASE, Cochrane Library, Ovid, EBSCO, WHO COVID-19 Database, Chinese Biomedical Databases, China National Knowledge Internet, VIP and WanFang Database. Medical Subject Headings and free-text terms for "COVID-19" AND "female" AND "fertility" will be performed. Eligibility criteria are as follows: population (female patients aged 13-49 years); exposure (infection with SARS-CoV-2); comparison (population without SARS-CoV-2 infections or latent SARS-CoV-2 infections); and outcome (female fertility, such as ovarian reserve function, uterine receptivity, oviducts status and menstruation status). Article screening and data extraction will be undertaken independently by two reviewers, and discrepancies will be resolved through discussion. We will use the I2 statistics to assess the heterogeneity and perform a meta-analysis when sufficiently homogeneous studies are provided. Otherwise, a narrative synthesis will be performed. We will explore the potential sources of heterogeneity using subgroup analyses and meta-regression.

Ethics and dissemination: Formal ethical approval is not required, and findings will be published in a peer-reviewed journal.

Prospero registration number: CRD42020189856.

Keywords: COVID-19; epidemiology; gynaecology.

Conflict of interest statement

Competing interests: None declared.

© Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

References

    1. World Health Organization . Coronavirus disease 2019 (COVID-2019) situation Report–49, 2020. Available: [Accessed 2 Sep 2020].
    1. Yang L, Liu S, Liu J, et al. . COVID-19: immunopathogenesis and immunotherapeutics. Signal Transduct Target Ther 2020;5:128. 10.1038/s41392-020-00243-2
    1. Cao X. COVID-19: immunopathology and its implications for therapy. Nat Rev Immunol 2020;20:269–70. 10.1038/s41577-020-0308-3
    1. XW X, XX W, Jiang XG. Clinical findings in a group of patients infected with the 2019 novel coronavirus (SARS-Cov-2) outside of Wuhan, China: retrospective case series. BMJ 2020;368. 10.1136/bmj.m606
    1. Gupta A, Madhavan MV, Sehgal K, et al. . Extrapulmonary manifestations of COVID-19. Nat Med 2020;26:1017–32. 10.1038/s41591-020-0968-3
    1. Aitken RJ. COVID-19 and human spermatozoa-Potential risks for infertility and sexual transmission? Andrology 2021;9:48–52. 10.1111/andr.12859
    1. Fu J, Zhou B, Zhang L, et al. . Expressions and significances of the angiotensin-converting enzyme 2 gene, the receptor of SARS-CoV-2 for COVID-19. Mol Biol Rep 2020;47:4383–92. 10.1007/s11033-020-05478-4
    1. Jing Y, Run-Qian L, Hao-Ran W, et al. . Potential influence of COVID-19/ACE2 on the female reproductive system. Mol Hum Reprod 2020;26:367–73. 10.1093/molehr/gaaa030
    1. Li R, Yin T, Fang F, et al. . Potential risks of SARS-CoV-2 infection on reproductive health. Reprod Biomed Online 2020;41:89–95. 10.1016/j.rbmo.2020.04.018
    1. Aassve A, Cavalli N, Mencarini L, et al. . The COVID-19 pandemic and human fertility. Science 2020;369:370–1. 10.1126/science.abc9520
    1. Li G, Tang D, Song B, et al. . Impact of the COVID-19 pandemic on partner relationships and sexual and reproductive health: cross-sectional, online survey study. J Med Internet Res 2020;22:e20961. 10.2196/20961
    1. Sills ES, Wood SH. An experimental model for Peri-conceptual COVID-19 pregnancy loss and proposed interventions to optimize outcomes. Int J Mol Cell Med 2020;9:180–7. 10.22088/IJMCM.BUMS.9.3.180
    1. Schwartz DA, Graham AL. Potential maternal and infant outcomes from (Wuhan) coronavirus 2019-nCoV infecting pregnant women: lessons from SARS, MERS, and other human coronavirus infections. Viruses 2020;12:194. 10.3390/v12020194
    1. Hsu AL, Guan M, Johannesen E, et al. . Placental SARS-CoV-2 in a pregnant woman with mild COVID-19 disease. J Med Virol 2021;93:1038-1044. 10.1002/jmv.26386
    1. Li W, Moore MJ, Vasilieva N, et al. . Angiotensin-Converting enzyme 2 is a functional receptor for the SARS coronavirus. Nature 2003;426:450–4. 10.1038/nature02145
    1. Lukassen S, Chua RL, Trefzer T, et al. . SARS-CoV-2 receptor ACE2 and TMPRSS2 are primarily expressed in bronchial transient secretory cells. Embo J 2020;39:e105114. 10.15252/embj.20105114
    1. Hikmet F, Méar L, Edvinsson Åsa, et al. . The protein expression profile of ACE2 in human tissues. Mol Syst Biol 2020;16:e9610. 10.15252/msb.20209610
    1. Zhou Y, Vedantham P, Lu K, et al. . Protease inhibitors targeting coronavirus and filovirus entry. Antiviral Res 2015;116:76–84. 10.1016/j.antiviral.2015.01.011
    1. Matsuyama S, Nagata N, Shirato K, et al. . Efficient activation of the severe acute respiratory syndrome coronavirus spike protein by the transmembrane protease TMPRSS2. J Virol 2010;84:12658–64. 10.1128/JVI.01542-10
    1. Hoffmann M, Kleine-Weber H, Schroeder S, et al. . SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell 2020;181:271–80. 10.1016/j.cell.2020.02.052
    1. Lippi G, Lavie CJ, Henry BM, et al. . Do genetic polymorphisms in angiotensin converting enzyme 2 (ACE2) gene play a role in coronavirus disease 2019 (COVID-19)? Clin Chem Lab Med 2020;58:1415–22. 10.1515/cclm-2020-0727
    1. Ace2 gene (protein coding). Available:
    1. Pereira VM, Reis FM, Santos RAS, et al. . Gonadotropin stimulation increases the expression of angiotensin-(1--7) and MAS receptor in the rat ovary. Reprod Sci 2009;16:1165–74. 10.1177/1933719109343309
    1. Mahdian S, Shahhoseini M, Moini A. COVID-19 mediated by basigin can affect male and female fertility. Int J Fertil Steril 2020;14:262–3. 10.22074/ijfs.2020.134702
    1. Chen L, Bi J, Nakai M, et al. . Expression of basigin in reproductive tissues of estrogen receptor-{alpha} or -{beta} null mice. Reproduction 2010;139:1057–66. 10.1530/REP-10-0069
    1. Chang H, Ni H, Ma X-H, et al. . Basigin expression and regulation in mouse ovary during the sexual maturation and development of corpus luteum. Mol Reprod Dev 2004;68:135–41. 10.1002/mrd.20060
    1. Mauvais-Jarvis F, Klein SL, Levin ER. Estradiol, progesterone, immunomodulation, and COVID-19 outcomes. Endocrinology 2020;161:bqaa127. 10.1210/endocr/bqaa127
    1. Shamseer L, Moher D, Clarke M, et al. . Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation. BMJ 2015;350:g7647. 10.1136/bmj.g7647
    1. Stroup DF, Berlin JA, Morton SC, et al. . Meta-Analysis of observational studies in epidemiology: a proposal for reporting. meta-analysis of observational studies in epidemiology (moose) group. JAMA 2000;283:2008–12. 10.1001/jama.283.15.2008
    1. Kumar S, Sharma A, Kshetrimayum C. Environmental & occupational exposure & female reproductive dysfunction. Indian J Med Res 2019;150:532–45. 10.4103/ijmr.IJMR_1652_17
    1. van Dorp W, Haupt R, Anderson RA, et al. . Reproductive function and outcomes in female survivors of childhood, adolescent, and young adult cancer: a review. J Clin Oncol 2018;36:2169–80. 10.1200/JCO.2017.76.3441
    1. Korevaar TIM, Mínguez-Alarcón L, Messerlian C, et al. . Association of thyroid function and autoimmunity with ovarian reserve in women seeking infertility care. Thyroid 2018;28:1349–58. 10.1089/thy.2017.0582
    1. Pascarella G, Strumia A, Piliego C, et al. . COVID-19 diagnosis and management: a comprehensive review. J Intern Med 2020;288:192–206. 10.1111/joim.13091
    1. Wells GA, Shea B, O’Connell D. The Newcastle-Ottawa scale (NOS) for assessing the quality of Nonrandomised studies in Metaanalyses. Ottawa: Ottawa Hospital Research Institute, 2019.
    1. Guyatt GH, Oxman AD, Vist GE, et al. . Grade: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ 2008;336:924–6. 10.1136/
    1. Egger M, Davey Smith G, Schneider M, et al. . Bias in meta-analysis detected by a simple, graphical test. BMJ 1997;315:629–34. 10.1136/bmj.315.7109.629
    1. Steiner AZ, Pritchard D, Stanczyk FZ, et al. . Association between biomarkers of ovarian reserve and infertility among older women of reproductive age. JAMA 2017;318:1367–76. 10.1001/jama.2017.14588
    1. Tal R, Seifer DB. Ovarian reserve testing: a user's guide. Am J Obstet Gynecol 2017;217:129–40. 10.1016/j.ajog.2017.02.027
    1. Johnson NP, Bagrie EM, Coomarasamy A, et al. . Ovarian reserve tests for predicting fertility outcomes for assisted reproductive technology: the International systematic collaboration of ovarian reserve evaluation protocol for a systematic review of ovarian reserve test accuracy. BJOG 2006;113:1472–80. 10.1111/j.1471-0528.2006.01068.x
    1. Jensen RE, Martins N, Parks MM. Public perception of female fertility: initial fertility, peak fertility, and age-related infertility among U.S. adults. Arch Sex Behav 2018;47:1507–16. 10.1007/s10508-018-1197-4
    1. Ahmed TA, Ahmed SM, El-Gammal Z, et al. . Oocyte aging: the role of cellular and environmental factors and impact on female fertility. Adv Exp Med Biol 2020;1247:109–23. 10.1007/5584_2019_456

Source: PubMed

3
Iratkozz fel